Volkswacht Bodensee - First US drug injection center aims to lead way on overdoses

In the room, there are eight open cubicles all equipped with a chair, a table and a mirror, the latter to quickly see "if anything goes wrong," says 29-year-old Mark, a regular visitor.

"You're monitored the whole time," explains the Californian, who asked to be identified by an alias.

"There's music playing. It's a very non-rushed environment unlike when you're using a public bathroom and people are knocking. That's rushed and you're more likely to miss your injection and cause an abscess," he adds.

Mark -- who is trying to reduce his reliance on tranquillizers and opiates, an addiction he has been fighting for two years -- visits the Overdose Prevention Center in East Harlem.

On the table lie syringes, rubber bands, gauze pads and a multicolored assortment of straws.

In two small rooms, visitors can smoke crack, a cheap derivative of cocaine. A larger room with a TV on the wall serves as a place of rest or for other activities.

Drug overdoses killed 2,062 people in New York alone in 2020, the height of the city's Covid-10 pandemic, with higher rates in poorer neighborhoods and Black communities.

Fewer than 1,500 died in 2019 and fewer than 1,000 in 2015.

Between April 2020 and April 2021, the United States recorded more than 100,000 drug deaths, a record for a 12-month period.

- Fentanyl -

Some 77 percent of cases in New York in 2020 involved the powerful synthetic fentanyl, which is often mixed with heroin and cocaine, a cocktail that killed "The Wire" star Michael K. Williams in September last year.

Fentanyl is "in everything," laments Sam Rivera, director of OnPoint NYC, which manages two drug injection centers in New York.

"Every time we tested" a drug, "it had fentanyl," he tells AFP.

It was in the context of soaring incidences of fentanyl overdoses that OnPoint NYC opened the center inside an anonymous building on 126th Street, with the support of the Democratic-led city government.

Rivera had already been helping users before, with care and prevention. He knew that when some would use the bathroom, they would also take drugs.

"There's a door in between and when we responded to an overdose there was some time between the actual onset of the overdose and then our response," he explains.

Being able to view users injecting themselves at a safe site, a model that has been used in parts of Europe for a while, is a "game changer," says Rivera.

Alsane Mezon, a 56-year-old medical assistant, is one person keeping a close watch, ready to intervene if a person reacts badly to the injection.

"It doesn't happen a lot, at least once a week," she says.

She has oxygen at her disposal, and if that is not enough, there is also naloxone, the main antidote to an opioid overdose.

Rivera told AFP at the beginning of February that staff had intervened during about 130 overdoses at the two sites.

In East Harlem, the center also offers medical care, acupuncture, laundry, hot meals, housing and help finding a job.

Some visitors "just come for a coffee and watch a movie," even after they stop using the center to inject, says Rivera, 59.

The injection rooms are a political flashpoint in the United States, with Republican senators accusing President Joe Biden this week of wanting to finance "crack pipes."

The federal government does not officially support the centers, but the Justice Department has said it is studying the program and having "discussions with state and local regulators about appropriate guardrails for such sites, as part of an overall approach to harm reduction and public safety."

- Opposition -

The center is also causing a stir locally, where East Harlem's community board called for a moratorium on any new facilities for drug users before the center opened.

Board president Xavier Santiago says the board fears that the center will attract more drug users to the area.

"It's not from a lack of empathy," he told AFP. "Many of our families, our friends have been impacted by substance abuse and overdose death."

Keith Humphreys, a psychiatry professor at Stanford who conducted a study with The Lancet on the opioid crisis, believes the centers can save lives but ultimately "have very little effect on the epidemic as a whole."

Instead, he'd rather see officials make it easier for the public to be able to get and administer naloxone.

For Rivera, there's no time to lose.

"We waited too long," he says.

B.Shevchenko--BTB